The CSE is committed to staying connected during the COVID-19 pandemic. In this Instagram live interview, Barrington Miller was joined by Jim Megann, Director of Sona Nanotech Inc., to discuss the groundbreaking work they’re doing to develop a fast-acting test for COVID-19. Megann explains how lateral flow nano-technology can pick out low concentrations of the virus in a test, their plan of action for prototyping and testing, and the importance of being in constant conversation with Health Canada and the FDA.
Follow us on Instagram at @CanadianSecuritiesExchange for more content like this.
